Frequency and causes of refractoriness in multiply transfused patients.
about
The value of alloantibody detection in predicting response to HLA-matched platelet transfusions.Refractoriness to platelet transfusion following double valve replacement in an ITP patient who had undergone splenectomy.Platelet alloantibodies in transfused patients.The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.Identification of platelet refractoriness in oncohematologic patients.Platelet refractoriness in acquired hemophagocytic syndrome.The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness.The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.Use of HLA- and HPA--matched platelets in alloimmunized patients.Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused PatientsPersistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in BrazilPlatelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractorinessThe international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical interventionPlatelet refractoriness--practical approaches and ongoing dilemmas in patient management.Leukoreduced red blood cell transfusions do not induce platelet glycoprotein antibodies in patients with sickle cell disease.The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type.Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support.Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusionsPlatelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions.How do I … manage the platelet transfusion-refractory patient?Induced Pluripotent Stem Cell-Derived Megakaryocytes and Platelets for Disease Modeling and Future Clinical Applications.Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products.Age of platelet concentrates and time to the next transfusion.
P2860
Q33196131-9FCBB9A2-BE25-41B6-80C0-6137C5AB2364Q33332991-8AA2588C-1FFB-43C8-B79C-F799A3958D81Q33337692-20D17A5E-6DC9-4398-B316-CE6CCD476916Q33364040-1A2C96F6-44DD-4043-9902-639EBBC3FE56Q33394648-9ABA0BAF-1EDB-4471-9E45-FC56DA0C4B83Q33395425-828563AC-4B27-4636-9EB0-FA90A6BB0E0CQ33407537-519E8468-72FF-420F-A9E8-FCCA22D5A074Q33411070-E1E56FE2-C356-4D5F-B2B4-B50B4D79DC23Q33441106-A85C8C59-E0DF-4CCA-B951-A2AD4A6845AEQ33503327-F9B9131E-D2CC-4698-9269-962264BEDF93Q34766786-9FE90427-319D-4723-80D2-8AEDB956AC14Q34777779-655B4862-2D89-4231-9B85-91B95EB0DBB3Q36674849-64C0E026-F46B-4F2D-9035-922BA43811C4Q37212610-97F17D61-90D9-4228-B1B5-EF70FA003938Q37216351-EA5D8850-EAD6-436C-8F03-6867161A57FCQ38551094-39CAEC50-0F12-4E4E-8A54-A115B8B17E71Q38844594-AF62344B-770D-4A95-AC6C-C41C79253B0DQ41264625-8A95A2D3-B2C7-4DDB-A4D9-90B9F6C09C03Q41919538-54247C1C-8776-4CF2-97D6-D64D2B9F5E3EQ42143229-F8188652-7E5D-453B-B7FA-D2DD29C3A2A7Q42454760-650B8321-6EF9-44C1-81BB-CC70278A40E3Q46106356-29785D23-0AE0-4019-85F5-61B97974CA56Q47667545-DF7EBF53-AEA8-4F00-A0BD-0FD09F834CA2Q47913269-74954F06-54CE-48CD-8BD8-F2F26F3DBBC3Q47965299-E0BE9678-81BB-4B4C-8FFD-D347B3E0A0C3Q48091096-B0090A45-0451-4D08-9777-B55D5FB31708
P2860
Frequency and causes of refractoriness in multiply transfused patients.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Frequency and causes of refractoriness in multiply transfused patients.
@en
type
label
Frequency and causes of refractoriness in multiply transfused patients.
@en
prefLabel
Frequency and causes of refractoriness in multiply transfused patients.
@en
P2093
P356
P1433
P1476
Frequency and causes of refractoriness in multiply transfused patients.
@en
P2093
Dittmann J
Hiddemann W
Schleyer E
P304
P356
10.1007/S002770050280
P577
1997-04-01T00:00:00Z